The Curbsiders Internal Medicine Podcast cover image

#329 Curing Hepatitis C: A Primary Care Primer

The Curbsiders Internal Medicine Podcast

00:00

Is on Treatment Monitoring Necessary?

The good news on side effects is they are not very common. I usually say ten to 15 % of people in the clinical trials will have something general like nausea, headache or fatigue. If you haven't identified rena failure, or a h v co infection, or heptetes b co infection, and we haven't in our case here, you don't need to check labs at all. There's one thing i want to just drop as a pearl here, which is this, this particular patient, i think you mentione, was obese. So maybe end of treatment, om anacend another set of labs, just maybe that metabolic panel. And what i'm doing there

Play episode from 01:03:43
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app